Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Preveceutical Medical Inc C.PREV

Alternate Symbol(s):  PRVCF

PreveCeutical Medical Inc. is a Canada-based health sciences company. The Company’s principal business activity is the development of options for preventive and curative therapies utilizing organic and nature identical products. The Company’s pipeline includes Cannabinoid Sol-Gel, Non-Addictive Analgesic, BSV Peptide Program and Dual Gene Therapy. Its Cannabinoid Sol-Gel is a cannabinoid-based nose-to-brain delivery system that provides relief to a range of indications from pain, inflammation, seizures, and neurological disorders. Its Dual Gene Therapy for curative and prevention therapies for diabetes and obesity. Its Nature Identical peptides for treatment of various ailments. Its BSV peptide program targets cancer progression. Its nonaddictive analgesic peptides as a replacement to the highly addictive analgesics such as morphine, fentanyl and oxycodone and a therapeutic product for treating athletes who suffer from concussions (mild traumatic brain injury).


CSE:PREV - Post by User

Bullboard Posts
Comment by spymasteron Oct 04, 2018 12:40pm
64 Views
Post# 28745520

RE:RE:RE:RE:RE:RE:RE:RE:RE:Maybe Dilution of shares

RE:RE:RE:RE:RE:RE:RE:RE:RE:Maybe Dilution of sharesi only see the following mentioned. according to this PPI achived $42m in revenue. PPI was taken out of Penta 5


Mr. Murray is an experienced businessman and entrepreneur, and currently is the chief executive officer of Penta 5 USA. In addition, Mr. Murray is the chief executive officer of PPi Technologies Group, formerly an affiliate of the Penta 5 group, which is the leading supplier in the United States of machinery for packaging both wet and dry products in StandUp pouches and trays, and last year achieved over $42-million in annual revenue. Mr. Murray has experience in accounting, quality control and production, as well as in marketing and sales activities. His past accomplishments include the development of 175 patents or patents pending and receiving the Ernst & Young entrepreneur of the year award in the distribution and manufacturing category.
Bullboard Posts